title: Should we routinely measure a proxy for insulin resistance as well as improve our modelling techniques to better predict the likelihood of coronary heart disease in people with type 2 diabetes? For debate.
authors.affiliation: Department of Endocrinology, Diabetes and Metabolism, University of Wales College of Medicine, Cardiff, Wales, UK.
authors.forename: Marc
authors.initials: M
authors.lastname: Evans
authors.forename: Phil
authors.initials: P
authors.lastname: McEwan
authors.forename: John R
authors.initials: JR
authors.lastname: Peters
authors.forename: Craig J
authors.initials: CJ
authors.lastname: Currie
mesh_terms: D003327:Coronary Disease / Q000517:prevention & control*; D003924:Diabetes Mellitus, Type 2 / Q000517:prevention & control*; D003925:Diabetic Angiopathies / Q000517:prevention & control*; D006801:Humans; D007333:Insulin Resistance / Q000502:physiology*; D008955:Models, Cardiovascular; D012044:Regression Analysis; D018570:Risk Assessment; D012307:Risk Factors